Hemophilia is a rare bleeding disorder in which the blood does not clot normally. People with hemophilia have little or no blood clotting factors, which are needed for normal blood clotting.
There are two types of hemophilia:
Hemophilia is inherited – it is passed on from parents to children. In rare cases, a child may be born to a family that has no history of hemophilia. This may be due to an unknown family history of hemophilia or due to a random, new mutation (an abnormal change) in genes carrying hemophilia.
In Canada, hemophilia A affects about 1 in 10,000 people. Hemophilia B is less common, affecting about 1 in 50,000 people. Hemophilia affects people of all races, colours, and ethnic backgrounds.
The most severe forms of hemophilia usually affect males only. Females may have severe hemophilia in certain instances, such as if the father has the disorder and the mother is a carrier. A carrier has the abnormal hemophilia genes but usually does not have the signs or symptoms of hemophilia. In some cases, women who are carriers may have symptoms of mild hemophilia.
Hemophilia is caused by mutations (abnormal changes) in the gene that makes clotting factors VIII or IX. These genes are located on the X chromosomes. Chromosomes are tiny structures found in every cell of our body; they hold our genes. Genes are the body’s instructions for what we look like, how we act, and how our bodies work. Chromosomes come in pairs. Females have two X chromosomes and males have one X and one Y chromosome. Only the X chromosome holds the genes that make clotting factors.
A male who has an abnormal hemophilia gene on his X chromosome will have hemophilia. A female must have the abnormal gene on both of her X chromosomes to have hemophilia. If a female has the abnormal gene on only one of her X chromosomes, she is a hemophilia carrier. She does not usually have the signs and symptoms of hemophilia but may pass on the abnormal gene to her children.
The major signs and symptoms of hemophilia are excessive bleeding and easy bruising. A person with hemophilia does not bleed more quickly than other people, but he or she may bleed for a longer period of time before the body can form a clot. The extent of bleeding depends on how severe the hemophilia is.
Bleeding from external wounds is usually not serious. Examples of external bleeding are:
Internal bleeding is much more serious. Examples of internal bleeding are:
A serious complication of hemophilia is bleeding in the brain, which can happen after a simple bump on the head or a more serious head injury, depending on how severe the hemophilia is. Signs and symptoms of bleeding in the brain are:
There are no differences in signs and symptoms between hemophilia A and B. Only special blood tests can tell which type of hemophilia you have. Knowing which type you have is important, as the treatment choices are different.
People with severe hemophilia can have serious bleeding problems early in life and are often diagnosed during the first year of life. Those with mild hemophilia might not be diagnosed until later in life.
Hemophilia is usually diagnosed by blood tests, family history, and any unusual signs of bleeding as described above. Blood tests are used to find out:
The test results will help confirm whether or not you have hemophilia, which type of hemophilia you have, and how severe it is. It is classified as mild, moderate, or severe depending on how much clotting factor VIII or IX is in your blood.
If a pregnant woman is known to be a carrier, doctors can perform tests before her baby’s birth to diagnose hemophilia. Testing is done by chorionic villus sampling (CVS) or amniocentesis. CVS is performed as early as Week 10, while amniocentesis is performed after Week 15.
The type of treatment depends on the type of hemophilia you have, how severe the hemophilia is, your daily activities, and any dental or medical procedures you may be having.
The main treatment for hemophilia is clotting factor replacement therapy. Clotting factor VIII or IX is infused into a vein. These clotting factors can be made from human blood that is screened and treated to prevent viral infections. With current technology, the risk of getting an infectious disease from human clotting factors is very small. Clotting factors can also be made in a lab instead of human blood; these are called recombinant clotting factors.
Replacement therapy may be given as prophylaxis, which means giving it on a regular basis to prevent bleeding, or on demand, only when an episode of bleeding occurs.
Problems that can come with factor replacement therapy include:
Very rarely, the body may form antibodies that attack the clotting factor replacement and prevent treatment from working. These antibodies are also called inhibitors. In hemophilia A, antibodies may develop in about 20% of people. In hemophilia B, antibodies may develop in about 1% of people. They are more common in people with severe hemophilia. Doctors may use a higher dose of factor replacement therapy in this case.
Other treatments for hemophilia include:
*All medications have both common (generic) and brand names. The brand name is what a specific manufacturer calls the product (e.g., Tylenol®). The common name is the medical name for the medication (e.g., acetaminophen). A medication may have many brand names, but only one common name. This article lists medications by their common names. For information on a given medication, check our Drug Information database. For more information on brand names, speak with your doctor or pharmacist.
All material copyright MediResource Inc. 1996 – 2019. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Source: www.medbroadcast.com/condition/getcondition/Hemophilia